Spire Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Spire Wealth Management's AMGN Position: Q3 2026 in Review
Spire Wealth Management increased its Amgen (AMGN) stake by 2.7% in Q3 2026, buying an estimated $47.4K and bringing the position to 4,503 shares worth $1.9M. The position accounts for 0.06% of the portfolio, ranked #277.
Spire Wealth Management first reported a position in AMGN in Q1 2021 and has held it in 23 quarters since. The position peaked at $5.72M in Q1 2025. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Spire Wealth Management held 4,503 shares of Amgen worth $1.9M as of Q3 2026.
- Spire Wealth Management bought 119 Amgen shares in Q3 2026, an estimated $47.4K.
- Amgen made up 0.06% of Spire Wealth Management's portfolio in Q3 2026, its #277 holding.
- Spire Wealth Management first reported a position in Amgen in Q1 2021 and has held it in 23 quarters since.
- Spire Wealth Management's Amgen position peaked at $5.72M in Q1 2025.
- 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Spire Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.